| Title |
Atypical antipsychotics for aggression and psychosis in Alzheimer's disease
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2006
|
| DOI | 10.1002/14651858.cd003476.pub2 |
| Pubmed ID | |
| Authors |
Clive G Ballard, Jonathan Waite, Jacqueline Birks |
| Abstract |
Aggression, agitation or psychosis occur in the majority of people with dementia at some point in the illness. There have been a number of trials of atypical antipsychotics to treat these symptoms over the last five years, and a systematic review is needed to evaluate the evidence in a balanced way. |
Twitter Demographics
The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 13% |
| Spain | 1 | 13% |
| Peru | 1 | 13% |
| United States | 1 | 13% |
| Unknown | 4 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 75% |
| Science communicators (journalists, bloggers, editors) | 1 | 13% |
| Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 349 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | <1% |
| Canada | 1 | <1% |
| Iceland | 1 | <1% |
| Belgium | 1 | <1% |
| Denmark | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 342 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 47 | 13% |
| Student > Master | 44 | 13% |
| Student > Bachelor | 42 | 12% |
| Student > Ph. D. Student | 32 | 9% |
| Other | 23 | 7% |
| Other | 98 | 28% |
| Unknown | 63 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 123 | 35% |
| Nursing and Health Professions | 24 | 7% |
| Psychology | 24 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 21 | 6% |
| Unspecified | 21 | 6% |
| Other | 63 | 18% |
| Unknown | 73 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2022.
All research outputs
#1,249,488
of 23,876,482 outputs
Outputs from Cochrane database of systematic reviews
#2,821
of 12,767 outputs
Outputs of similar age
#3,237
of 158,601 outputs
Outputs of similar age from Cochrane database of systematic reviews
#4
of 61 outputs
Altmetric has tracked 23,876,482 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,767 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.6. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,601 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.